1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Rescue therapy outcomes with GP IIb/IIIa inhibitors versus fibrinolytics
OutcomeGP IIb/IIIa Inhibitor % (95% CI)I2Fibrinolytic % (95% CI)I2P Value
Postoperative clinical stroke14.0 (8.0–23.0)6527.0 (11.0–51.0)53.20
Postoperative infarct on imaging28.0 (19.0–39.0)5639.0 (19.0–63.0)0.42
Postoperative hemorrhage7.0 (4.0–10.0)014.0 (6.0–31.0)26.12
Perioperative morbidity from stroke/hemorrhage11.0 (7.0–16.0)1029.0 (13.0–55.0)55.04
Perioperative mortality from stroke/hemorrhage6.0 (4.0–9.0)012.0 (5.0–25.0)0.16
Long-term good neurologic outcome82.0 (78.0–86.0)065.0 (42.0–83.0)43.07
Long-term morbidity16.0 (11.0–21.0)1335.0 (17.0–58.0)43.04
Recanalization rate72.0 (64.0–78.0)4950.0 (28.0–73.0)37.08